These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 1425115

  • 1. Difference between islet cell antibodies and autoantibodies to glutamic acid decarboxylase-containing Purkinje cells in IDDM.
    Kobayashi T, Nakanishi K, Murase T, Kosaka K.
    Diabetes Care; 1992 Oct; 15(10):1435-6. PubMed ID: 1425115
    [No Abstract] [Full Text] [Related]

  • 2. GAD antibodies seldom disappear in slowly progressive IDDM.
    Kobayashi T, Nakanishi K, Okubo M, Murase T, Kosaka K.
    Diabetes Care; 1996 Sep; 19(9):1031. PubMed ID: 8875105
    [No Abstract] [Full Text] [Related]

  • 3. Presence of autoantibodies to carbonic anhidrase II and lactoferrin in type 1 diabetes: proposal of the concept of autoimmune exocrinopathy and endocrinopathy of the pancreas.
    Taniguchi T, Okazaki K, Okamoto M, Seko S, Uchida K, Seino Y.
    Diabetes Care; 2001 Sep; 24(9):1695-6. PubMed ID: 11522728
    [No Abstract] [Full Text] [Related]

  • 4. Persisting antibodies to glutamic acid decarboxylase in type 1 (insulin-dependent) diabetes mellitus are not associated with neuropathy.
    Tuomi T, Zimmet PZ, Rowley MJ, Serjeantson SW, Mackay IR.
    Diabetologia; 1993 Jul; 36(7):685. PubMed ID: 8359590
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cellular immune response to GAD in type 1 diabetes with residual beta-cell function.
    Fukui M, Nakamura N, Nakano K, Kondo M.
    Diabetes Care; 1999 Oct; 22(10):1758-9. PubMed ID: 10526760
    [No Abstract] [Full Text] [Related]

  • 7. Heterogeneity in the occurrence of a subset of autoantibodies to glutamic acid decarboxylase in autoimmune polyendocrine patients with islet cell antibodies.
    Davenport C, Radford PM, Al-Bukhari TA, Lai M, Bottazzo GF, Todd I.
    Clin Exp Immunol; 1998 Mar; 111(3):497-505. PubMed ID: 9528889
    [Abstract] [Full Text] [Related]

  • 8. GAD antibodies in IDDM in Thailand.
    Rattarasarn C, Aguilar-Diosdado M, Soonthornpun S, Patarakijvanich N, Jaruratanasirikul S.
    Diabetes Care; 1996 Jun; 19(6):674-5. PubMed ID: 8725876
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antibodies to glutamic acid decarboxylase discriminate major types of diabetes mellitus.
    Rowley MJ, Mackay IR, Chen QY, Knowles WJ, Zimmet PZ.
    Diabetes; 1992 Apr; 41(4):548-51. PubMed ID: 1607079
    [Abstract] [Full Text] [Related]

  • 11. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
    Whittingham S, Byron SL, Tuomilehto J, Zimmet PZ, Myers MA, Vidgren G, Rowley MJ, Feeney SJ, Koskela P, Tuomilehto-Wolf E, Mackay IR.
    Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
    [Abstract] [Full Text] [Related]

  • 12. Cytoplasmic islet cell antibodies recognize distinct islet antigens in IDDM but not in stiff man syndrome.
    Richter W, Seissler J, Northemann W, Wolfahrt S, Meinck HM, Scherbaum WA.
    Diabetes; 1993 Nov; 42(11):1642-8. PubMed ID: 8405707
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies.
    Kawasaki E, Takino H, Yano M, Uotani S, Matsumoto K, Yamaguchi Y, Akazawa S, Nagataki S.
    J Autoimmun; 1994 Dec; 7(6):791-802. PubMed ID: 7888036
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of GAD65 and IA-2 autoantibodies in IDDM patients affected by diabetic nephropathy.
    Zerbini G, Bazzigaluppi E, Mangili R, Bosi E, Bonifacio E.
    Diabetologia; 1997 Apr; 40(4):485. PubMed ID: 9112029
    [No Abstract] [Full Text] [Related]

  • 15. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease.
    Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR.
    Diabetes; 1993 Feb; 42(2):359-62. PubMed ID: 8425674
    [Abstract] [Full Text] [Related]

  • 16. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase.
    Myers MA, Rabin DU, Rowley MJ.
    Diabetes; 1995 Nov; 44(11):1290-5. PubMed ID: 7589826
    [Abstract] [Full Text] [Related]

  • 17. High prevalence of autoantibodies to glutamic acid decarboxylase in long-standing IDDM is not a marker of symptomatic autonomic neuropathy.
    Zanone MM, Petersen JS, Peakman M, Mathias CJ, Watkins PJ, Dyrberg T, Vergani D.
    Diabetes; 1994 Sep; 43(9):1146-51. PubMed ID: 8070615
    [Abstract] [Full Text] [Related]

  • 18. Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity.
    Christie MR, Genovese S, Cassidy D, Bosi E, Brown TJ, Lai M, Bonifacio E, Bottazzo GF.
    Diabetes; 1994 Oct; 43(10):1254-9. PubMed ID: 7926297
    [Abstract] [Full Text] [Related]

  • 19. Towards a World Health Organization (WHO) approved standard sample for islet cell antibodies, GAD65 and IA-2 autoantibodies.
    Lernmark A, Kolb H, Mire-Sluis T.
    Diabetologia; 1999 Mar; 42(3):381-2. PubMed ID: 10096794
    [No Abstract] [Full Text] [Related]

  • 20. Anti-GAD antibodies in Chinese patients with youth and adult-onset IDDM and NIDDM.
    Thai AC, Ng WY, Loke KY, Lee WR, Lui KF, Cheah JS.
    Diabetologia; 1997 Dec; 40(12):1425-30. PubMed ID: 9447950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.